Free Trial

OnKure Therapeutics (OKUR) Institutional Ownership

OnKure Therapeutics logo
$4.52 -0.08 (-1.74%)
Closing price 04:00 PM Eastern
Extended Trading
$4.28 -0.24 (-5.40%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for OnKure Therapeutics (NASDAQ:OKUR)

Current
Institutional Ownership
Percentage
90.98%
Number of
Institutional Buyers
(last 12 months)
16
Total
Institutional Inflows
(last 12 months)
$15.09M
Number of
Institutional Sellers
(last 12 months)
7
Total
Institutional Outflows
(last 12 months)
$1.89M
Get OKUR Insider Trade Alerts

Want to know when executives and insiders are buying or selling OnKure Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

OKUR Institutional Buying and Selling by Quarter

OnKure Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
3/20/2026 Hsbc Holdings PLC19,973$58K0.0%N/A0.147%
2/18/2026XTX Topco Ltd17,801$52K0.0%N/A0.131%
2/17/2026ADAR1 Capital Management LLC1,014,158$2.94M0.2%N/A7.486%
2/17/2026Cantor Fitzgerald L. P.445,078$1.29M0.0%-9.5%3.285%
2/17/2026Kotler Kevin197,691$573K0.1%N/A1.459%
2/16/2026Barclays PLC27,242$79K0.0%+4,286.8%0.201%
2/13/2026Prosight Management LP816,909$2.37M0.5%+204.9%6.029%
2/12/2026Jane Street Group LLC19,414$56K0.0%N/A0.143%
2/12/2026Renaissance Technologies LLC247,350$717K0.0%+40.7%1.826%
2/12/2026Rosalind Advisors Inc.730,488$2.12M0.8%N/A5.392%
2/11/2026Highbridge Capital Management LLC542,361$1.57M0.1%-16.6%4.003%
2/9/2026Geode Capital Management LLC77,469$225K0.0%-8.7%0.572%
12/1/2025Cantor Fitzgerald L. P.491,863$1.35M0.0%-26.5%3.630%
11/17/2025Citadel Advisors LLC1,016,613$2.80M0.0%-6.7%7.503%
11/17/2025Cantor Fitzgerald L. P.491,863$1.35M0.0%-26.5%3.630%
11/14/2025Shay Capital LLC917,934$2.52M0.2%+17.4%6.784%
11/14/2025Bridgeway Capital Management LLC19,500$54K0.0%-22.0%0.144%
11/14/2025Prosight Management LP267,959$737K0.2%+67.8%1.980%
11/10/2025Highbridge Capital Management LLC650,218$1.79M0.1%-2.0%4.806%
11/7/2025GSA Capital Partners LLP59,224$163K0.0%+172.1%0.438%
11/7/2025Vanguard Group Inc.678,226$1.87M0.0%-4.0%5.013%
8/15/2025Shay Capital LLC782,046$1.87M0.2%+417.8%5.789%
8/15/2025Rangeley Capital LLC29,902$71K0.1%N/A0.221%
8/15/2025Acorn Capital Advisors LLC2,839,674$6.79M4.4%+97.2%21.019%
8/13/2025Affinity Asset Advisors LLC347,990$832K0.1%-11.7%2.576%
8/12/2025XTX Topco Ltd10,643$25K0.0%N/A0.079%
8/12/2025Highbridge Capital Management LLC663,607$1.59M0.1%+51.2%4.912%
8/8/2025Bailard Inc.14,239$34K0.0%N/A0.105%
5/16/2025ADAR1 Capital Management LLC10,000$43K0.0%N/A0.074%
5/14/2025Affinity Asset Advisors LLC394,159$1.70M0.2%+173.4%2.934%
2/17/2025Vestal Point Capital LP635,000$5.46M0.3%N/A19.012%
2/17/2025Two Sigma Advisers LP14,228$122K0.0%N/A0.426%
2/17/2025Tang Capital Management LLC294,626$2.53M0.2%N/A8.821%
2/17/2025Shay Capital LLC15,016$129K0.0%N/A0.450%
2/17/2025Sphera Funds Management LTD.87,354$751K0.1%N/A2.615%
2/17/2025Prosight Management LP63,754$548K0.2%N/A1.909%
2/17/2025OMERS ADMINISTRATION Corp12,100$104K0.0%N/A0.362%
2/17/2025NEA Management Company LLC478,548$4.12M0.2%N/A14.328%
2/17/2025Millennium Management LLC144,099$1.24M0.0%N/A4.314%
2/17/2025Deep Track Capital LP523,989$4.51M0.2%N/A15.688%
2/17/2025Cubist Systematic Strategies LLC20,549$177K0.0%N/A0.615%
2/17/2025Cantor Fitzgerald L. P.35,700$294K0.0%N/A1.069%
2/17/2025Citadel Advisors LLC1,074,314$8.78M0.0%N/A32.165%
2/17/2025Bank of America Corp DE249,642$2.15M0.0%N/A7.474%
2/17/2025683 Capital Management LLC43,371$373K0.0%N/A1.299%
2/17/2025Acorn Capital Advisors LLC1,439,674$12.38M6.8%N/A43.104%
2/14/2025Samsara BioCapital LLC824,155$7.09M1.0%N/A24.675%
2/14/2025Nantahala Capital Management LLC54,777$471K0.0%N/A1.640%
2/14/2025Northern Trust Corp19,177$165K0.0%N/A0.574%
2/14/2025Boothbay Fund Management LLC78,021$671K0.0%N/A2.336%
2/14/2025Altium Capital Management LLC218,386$1.88M0.5%N/A6.539%
2/13/2025Affinity Asset Advisors LLC144,159$1.24M0.2%N/A4.316%
2/13/2025Carlyle Group Inc.269,895$2.33M0.5%N/A8.081%
2/13/2025Walleye Capital LLC13,495$116K0.0%N/A0.404%
2/13/2025XTX Topco Ltd18,633$160K0.0%N/A0.558%
2/13/2025Barclays PLC8,741$75K0.0%N/A0.262%
2/13/2025Renaissance Technologies LLC47,450$408K0.0%N/A1.421%
2/12/2025Aldebaran Capital LLC45,572$392K0.4%N/A1.363%
2/12/2025Aisling Capital Management LP88,607$762K0.3%N/A2.651%
2/12/2025Geode Capital Management LLC76,599$659K0.0%N/A2.291%
2/12/2025Highbridge Capital Management LLC399,743$3.44M0.1%N/A11.958%


OKUR Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of OKUR shares?

During the previous two years, 41 institutional investors and hedge funds held shares of OnKure Therapeutics. The most heavily invested institutionals were Samsara BioCapital LLC ($7.09M), Acorn Capital Advisors LLC ($6.79M), Vestal Point Capital LP ($5.46M), Deep Track Capital LP ($4.51M), NEA Management Company LLC ($4.12M), ADAR1 Capital Management LLC ($2.94M), and Citadel Advisors LLC ($2.80M).Learn more on OnKure Therapeutics' institutional investors.

What percentage of OnKure Therapeutics' stock is owned by institutional investors?

90.98% of OnKure Therapeutics' stock is owned by institutional investors. Learn more on OKUR's institutional investor holdings.

Which institutional investors have been buying OnKure Therapeutics' stock?

Of the 39 institutional investors that purchased OnKure Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Acorn Capital Advisors LLC ($2.84M), Citadel Advisors LLC ($1.07M), ADAR1 Capital Management LLC ($1.02M), Samsara BioCapital LLC ($824.16K), Shay Capital LLC ($781.91K), Rosalind Advisors Inc. ($730.49K), and Prosight Management LP ($720.97K).

How much institutional buying is happening at OnKure Therapeutics?

Institutional investors have bought a total of 5,498,912 shares in the last 24 months. This purchase volume represents approximately $15.09M in transactions.

Which of OnKure Therapeutics' major shareholders have been selling company stock?

The following institutional investors have sold OnKure Therapeutics stock in the last 24 months: Cantor Fitzgerald L. P. ($402.14K), Highbridge Capital Management LLC ($121.25K), Citadel Advisors LLC ($72.70K), Affinity Asset Advisors LLC ($46.17K), Vanguard Group Inc. ($28.51K), Geode Capital Management LLC ($7.43K), and Bridgeway Capital Management LLC ($5.50K).

How much institutional selling is happening at OnKure Therapeutics?

Institutional investors have sold a total of 683,682 shares in the last 24 months. This volume of shares sold represents approximately $1.89M in transactions.



This page (NASDAQ:OKUR) was last updated on 5/5/2026 by MarketBeat.com Staff.
From Our Partners